| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0016 | 1 |